International Consortium for Polynucleotide Synthesis (ICPS)

 

GENEART COdon Blue Heron Biotechnology CODA BaseClear Bioneer IDT

 

 

About the ICPS

In the summer of 2006, leading international synthetic biology companies joined together to form the International Consortium for Polynucleotide Synthesis (ICPS). The primary mission of the ICPS is to promote safety and security in the promising field of synthetic biology. As part of this mission, the ICPS member organizations will work together to develop technologies that improve safety and security in synthetic biology. In addition, the ICPS plans to work with governmental organizations to help facilitate the creation of a governance framework and associated safety protocols to foster an appropriate regulatory environment for the synthetic biology industry.

What is Synthetic Biology?

Synthetic biology is the construction of engineered biological components and systems. Fueled by the recent rapid advances in DNA synthesis technology, synthetic biology has tremendous potential to accelerate biological research. The applications of this powerful technology are far and wide and include rapid vaccine development, vastly improved therapeutics, renewable energy production, and many others.

Resources:

 

A Practical Perspective on DNA Synthesis and Biological Security
(full text download here)

 

Authors:

Hans Bugl1,2, John P. Danner1,3, Robert J. Molinari1,4, John Mulligan1,5, David A. Roth1,4, Han-Oh Park6, Bas Reichert7, Ralf Wagner1,2,8, Bruce Budowle9, Robert M. Scripp9, Jenifer A. L. Smith9, Scott J. Steele9, George Church3,10,12, & Drew Endy3,11,12

Affiliations:

1 International Consortium for Polynucleotide Synthesis (ICPS)

2 GENEART GA. Regensburg, Germany

3 Codon Devices, Inc. Cambridge, MA, USA

4 CODA Genomics, Inc. Laguna Hills, CA, USA

5 Blue Heron Biotechnology, Inc. Bothell, WA, USA

6 Bioneer Corp., Ltd., & Inc. Daedeok-gu, S. Korea

7 BaseClear, B.V., Netherlands.

8 University of Regensburg Molecular Virology, Germany

9 United States Federal Bureau of Investigation

10 Harvard Medical School, Department of Genetics

11 Massachusetts Institute of Technology, Division of Biological Engineering

12 US National Science Foundation, Synthetic Biology Engineering Research Center

 

Contacts:

John Mulligan, Chairman, ICPS

Damon Terrill President and COO, ICPS.

Ralf Wagner, European Chairman, ICPS

hans.buegl@geneart.com ,

bruce.budowle@ic.fbi.gov ,

droth@codagenomics.com ,

mole@codagenomics.com ,

George Church ,

endy@mit.edu

 

 

Affiliated members: Markus Fischer, Entelechon GmbH; Dr. Hubert Bernauer, ATG:biosynthetics GmbH; Dr. Heinz Schwer, Sloning BioTechnology GmbH; Philipp Habermeier, Febit-synbio GmbH; Peer StÃhler, Febit biotech GmbH; MWG Biotech (Industrieverband synthetische Biologie, Industry Association of Synthetic Biology IASB); Dr. Matthias Pfeiffer, Medigenomix GmbH